Adoptive transfer of antithyrotropin receptor (TSHR) autoimmunity from TSHR knockout mice to athymic nude mice

Endocrinology

Volumn 153, Issue 4, 2012, Pages 2034-2042

  Nakahara, Mami ^a   Johnson, Kristian ^b   Eckstein, Anja ^b   Taguchi, Ryo ^c   Yamada, Masanobu ^c   Abiru, Norio ^a   Nagayama, Yuji ^a  

^a NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

^c GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; INTERLEUKIN 2 RECEPTOR ALPHA; PROGRAMMED DEATH 1 LIGAND 1; THYROID STIMULATING IMMUNOGLOBULIN; THYROTROPIN RECEPTOR; THYROTROPIN RECEPTOR ANTIBODY; THYROXINE;

ADENOVIRUS; ADIPOSE TISSUE; ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; AUTOIMMUNITY; CELL INFILTRATION; CONTROLLED STUDY; ENDOCRINE OPHTHALMOPATHY; EXTRAOCULAR MUSCLE; FEMALE; HISTOPATHOLOGY; HORMONE BLOOD LEVEL; HYPERTHYROIDISM; HYPOTHYROIDISM; IMMUNE RESPONSE; KNOCKOUT MOUSE; MACROPHAGE; MOUSE; NONHUMAN; NUDE MOUSE; ORBIT INFLAMMATION; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SPLEEN CELL; T CELL DEPLETION;

ADOPTIVE TRANSFER; ANIMALS; ANTIBODIES, ANTI-IDIOTYPIC; AUTOIMMUNITY; DISEASE MODELS, ANIMAL; FEMALE; GRAVES DISEASE; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; MICE, NUDE; ORBITAL DISEASES; RECEPTORS, THYROTROPIN; SPLEEN; THYROID GLAND; TRANSPLANTS;

EID: 84859410504     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2011-1846     Document Type: Article

References (35)

1. Eckstein AK, Johnson KT, Thanos M, Esser J, Ludgate M 2009 Current insights into the pathogenesis of Graves' orbitopathy. Horm Metab Res 41:456-464
2. Bahn RS 2010 Graves' ophthalmopathy. N Engl J Med 362:726-738
3. Wiersinga WM 2011 Autoimmunity in Graves' ophthalmopathy: the result of an unfortunate marriage between TSH receptors and IGF-1 receptors? J Clin Endocrinol Metab 96:2386-2394
4. Rapoport B, Alsabeh R, Aftergood D, McLachlan SM 2000 Elephantiasic pretibial myxedema: insight into and a hypothesis regarding the pathogenesis of the extrathyroidal manifestations of Graves' disease. Thyroid 10:685-692
5. Nagayama Y, Kita-Furuyama M, Ando T, Nakao K, Mizuguchi H, Hayakawa T, Eguchi K, Niwa M 2002 A novel murine model of Graves' hyperthyroidism with intramuscular injection of adenovirus expressing the thyrotropin receptor. J Immunol 168:2789-2794 (Pubitemid 34211657)
6. Chen CR, Pichurin P, Nagayama Y, Latrofa F, Rapoport B, McLachlan SM 2003 The thyrotropin receptor autoantigen in Graves disease is the culprit as well as the victim. J Clin Invest 111:1897-1904 (Pubitemid 38057734)
7. Nagayama Y, Kaufman KD, Seto P, Rapoport B 1989 Molecular cloning, sequence and functional expression of the cDNA for the human thyrotropin receptor. Biochem Biophys Res Commun 165:1184-1190 (Pubitemid 20029833)
8. Stein SA, Oates EL, Hall CR, Grumbles RM, Fernandez LM, Taylor NA, Puett D, Jin S 1994 Identification of a point mutation in the thyrotropin receptor of the hyt/hyt hypothyroid mouse. Mol Endocrinol 8:129-138
9. Rapoport B, Williams RW, Chen CR, McLachlan SM 2010 Immunoglobulin heavy chain variable region genes contribute to the induction of thyroid-stimulating antibodies in recombinant inbred mice. Genes Immun 11:254-263
10. Nakahara M, Mitsutake N, Sakamoto H, Chen CR, Rapoport B, McLachlan SM, Nagayama Y 2010 Enhanced response to mouse thyroid-stimulating hormone (TSH) receptor immunization in TSH receptor-knockout mice. Endocrinology 151:4047-4054
11. Marians RC, Ng L, Blair HC, Unger P, Graves PN, Davies TF 2002 Defining thyrotropin-dependent and -independent steps of thyroid hormone synthesis by using thyrotropin receptor-null mice. Proc Natl Acad Sci USA 99:15776-15781 (Pubitemid 35404006)
12. Saitoh O, Nagayama Y 2006 Regulation of Graves' hyperthyroidism with naturally occurring CD4+CD25+ regulatory T cells in a mouse model. Endocrinology 147:2417-2422
13. Shibusawa N, Yamada M, Hirato J, Monden T, Satoh T, Mori M 2000 Requirement of thyrotropin-releasing hormone for the postnatal functions of pituitary thyrotrophs: ontogeny study of congenital tertiary hypothyroidism in mice. Mol Endocrinol 14:137-146 (Pubitemid 32260333)
14. Horie I, Abiru N, Nagayama Y, Kuriya G, Saitoh O, Ichikawa T, Iwakura Y, Eguchi K 2009 T helper type 17 immune response plays an indispensable role for development of iodine-induced autoimmune thyroiditis in nonobese diabetic-H2h4 mice. Endocrinology 150:5135-5142
15. McLachlan SM, Nagayama Y, Pichurin PN, Mizutori Y, Chen CR, Misharin A, Aliesky HA, Rapoport B 2007 The link between Graves' disease and Hashimoto's thyroiditis: a role for regulatory T cells. Endocrinology 148:5724-5733 (Pubitemid 350146191)
16. Sprent J, Webb SR 1995 Intrathymic and extrathymic clonal deletion of T cells. Curr Opin Immunol 7:196-205
17. Surh CD, Sprent J 2000 Homeostatic T cell proliferation: how far can T cells be activated to self-ligands? J Exp Med 192:F9-F14 (Pubitemid 30666246)
18. Annacker O, Burlen-Defranoux O, Pimenta-Araujo R, Cumano A, Bandeira A 2000 Regulatory CD4 T cells control the size of the peripheral activated/memory CD4 T cell compartment. J Immunol 164:3573-3580 (Pubitemid 30169809)
19. Kaneda T, Honda A, Hakozaki A, Fuse T, Muto A, Yoshida T 2007 An improved Graves' disease model established by using in vivo electroporation exhibited long-term immunity to hyperthyroidism in BALB/c mice. Endocrinology 148:2335-2344 (Pubitemid 46997085)
20. Curran MA, Montalvo W, Yagita H, Allison JP 2010 PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors. Proc Natl Acad Sci USA 107:4275-4280
21. Yu P, Steel JC, Zhang M, Morris JC, Waldmann TA 2010 Simultaneous blockade of multiple immune system inhibitory checkpoints enhances antitumor activity mediated by interleukin-15 in a murine metastatic colon carcinoma model. Clin Cancer Res 16:6019-6028
22. Amagai M, Tsunoda K, Suzuki H, Nishifuji K, Koyasu S, Nishikawa T 2000 Use of autoantigen-knockout mice in developing an active autoimmune disease model for pemphigus. J Clin Invest 105:625-631 (Pubitemid 30146509)
23. Aoki-Ota M, Tsunoda K, Ota T, Iwasaki T, Koyasu S, Amagai M, Nishikawa T 2004 A mouse model of pemphigus vulgaris by adoptive transfer of naive splenocytes from desmoglein 3 knockout mice. Br J Dermatol 151:346-354 (Pubitemid 39215148)
24. Naik VM, Naik MN, Goldberg RA, Smith TJ, Douglas RS 2010 Immunopathogenesis of thyroid eye disease: emerging paradigms. Surv Ophthalmol 55:215-226
25. Tamai H, Hirota Y, Kasagi K, Matsubayashi S, Kuma K, Iida Y, Konishi J, Okimura MC, Walter RM, Kumagai LF, et al. 1987 The mechanism of spontaneous hypothyroidism in patients with Graves'disease after antithyroid drug treatment. J Clin Endocrinol Metab 64:718-722 (Pubitemid 17044538)
26. Smith TJ, Hoa N 2004 Immunoglobulins from patients with Graves'disease induce hyaluronan synthesis in their orbital fibroblasts through the self-antigen, insulin-like growth factor-I receptor. J Clin Endocrinol Metab 89:5076-5080 (Pubitemid 39391451)
27. Wall JR, Lahooti H 2010 Pathogenesis of thyroid eye disease - does autoimmunity against the TSH receptor explain all cases? Endokrynol Pol 61:222-227
28. Costagliola S, Rodien P, Many MC, Ludgate M, Vassart G 1998 Genetic immunization against the human thyrotropin receptor causes thyroiditis and allows production of monoclonal antibodies recognizing the native receptor. J Immunol 160:1458-1465 (Pubitemid 28093448)
29. Many MC, Costagliola S, Detrait M, Denef F, Vassart G, Ludgate MC 1999 Development of an animal model of autoimmune thyroid eye disease. J Immunol 162:4966-4974 (Pubitemid 29314904)
30. Yamada M, Li AW, West KA, Chang CH, Wall JR 2002 Experimental model for ophthalmopathy in BALB/c and outbred (CD-1) mice genetically immunized with G2s and the thyrotropin receptor. Autoimmunity 35:403-413 (Pubitemid 35252232)
31. Baker G, Mazziotti G, von Ruhland C, Ludgate M 2005 Reevaluating thyrotropin receptor-induced mouse models of graves' disease and ophthalmopathy. Endocrinology 146:835-844 (Pubitemid 40129841)
32. Chen MH, Liao SL, Chang TC, Chuang LM 2008 Role of macrophage infiltration in the orbital fat of patients with Graves' ophthalmopathy. Clin Endocrinol (Oxf) 69:332-337
33. Kumar S, Bahn RS 2003 Relative overexpression of macrophage-derived cytokines in orbital adipose tissue from patients with graves'ophthalmopathy. J Clin Endocrinol Metab 88:4246-4250 (Pubitemid 37153727)
34. Aniszewski JP, Valyasevi RW, Bahn RS 2000 Relationship between disease duration and predominant orbital T cell subset in Graves'ophthalmopathy. J Clin Endocrinol Metab 85:776-780 (Pubitemid 32273668)
35. Zhao SX, Tsui S, Cheung A, Douglas RS, Smith TJ, Banga JP 2011 Orbital fibrosis in a mouse model of Graves' disease induced by genetic immunization of thyrotropin receptor cDNA. J Endocrinol 210:369-377